‘She is retired’: Do I dip into my 401(k) to pay my mother’s $30,000 credit-card debt?
“I want her to live on her Social Security instead of using it to pay off her credit-card debt.”
“I want her to live on her Social Security instead of using it to pay off her credit-card debt.”
Returning to the office — even just a few days a week — might be what fully remote workers actually need.
A modern-day gold rush is giving a big boost to U.S. GDP.
Smart glasses could become the definitive hardware design of the AI era — if consumers buy in to the idea.
<p style="float:right; margin:0 0 10px 15px; width:240px;"><img src="https://s3-images.ctmedia.io/media/article-covers/hi-spotlight-for-crypto-recovery.jpg" alt=" SecondFi targets two-week recovery after Cardano wallet exploit" class="type:primaryImage"></p><p>SecondFi says it has completed forensic investigations, taken a final balance snapshot and is preparing to return assets.</p>
The company’s pivot toward offering hardware access to rivals could hamstring its own AI goals.
The equal-weighted version of the S&P 500 outperformed its traditional capitalization-weighted sibling this week by the widest margin in six years.
<p style="float:right; margin:0 0 10px 15px; width:240px;"><img src="https://s3-images.ctmedia.io/media/article-covers/hi-european-union-moves-to-regulate-crypto-asset-market2.jpg" alt="EU lawmakers urge assessing DeFi, staking, NFT regulation" class="type:primaryImage"></p><p>The nonbinding report outlines Parliament's vision for future EU crypto regulation and warns against national MiCA rules.</p>
<p style="float:right; margin:0 0 10px 15px; width:240px;"><img src="https://s3-images.ctmedia.io/media/article-covers/hi-types-of-consensus-mechanisms-in-blockchain-1.jpg" alt="Securitize expects to raise $400M ahead of public debut" class="type:primaryImage"></p><p>Securitize says less than 30% of shareholders in the acquisition firm taking it public elected to redeem, giving it an expected $400 million on its upcoming debut.</p>
<p style="float:right; margin:0 0 10px 15px; width:240px;"><img src="https://s3-images.ctmedia.io/media/article-covers/article-covers-202708-legacy-altcoins-surge-is-a-new-altcoin-season-starting-to-emerge.jpg" alt="SOL reclaims $72, but onchain data flags weakening momentum" class="type:primaryImage"></p><p>Solana found strength from tokenized stock trading on its network, but a declining TVL and DEX volumes point to fading momentum. </p>
<p style="float:right; margin:0 0 10px 15px; width:240px;"><img src="https://s3-images.ctmedia.io/media/article-covers/analys-analytics-bisiness-man-woman-up-city-takeoff-cftc.jpg" alt="US senators urge CFTC probe Polymarket over ‘deceptive marketing’" class="type:primaryImage"></p><p>Senators John Curtis and Adam Schiff are concerned about the CFTC’s enforcement ability after a “troubling” report on Polymarket’s advertising.</p>
Old Ether wallets moved 37,806 ETH as long-term whale profitability turned negative for the first time since 2019, signaling mixed sentiment among large holders.
Oracle’s stock missed out on the broader software rally, as the company is tied to OpenAI’s success through its cloud-infrastructure business.
Oil futures settled lower to post a third-straight weekly loss on Friday, but moved up in extended trading after the U.S. military confirmed a retaliatory strike on Iran.
It one of the worst weeks for tech stocks of the year, and Wall Street spent much of it confronting a question it had been too euphoric to ask: what exactly are we getting for all this AI spending?
War-risk premiums narrowed considerably in recent days but could increase again.
Elon Musk’s company made a splash earlier this week with a $25 billion bond deal, less than two weeks after it raised tens of billions of dollars in cash.
Kevin Warsh, the new Federal Reserve chair, is helping coax Treasury yields lower by talking tough on inflation.
Doubts over the U.S.-Iran peace deal and the AI buildup mean a rate hike is possible, the Minneapolis Fed president says.
Shares of AbbVie, Eli Lilly and Johnson & Johnson were on track to hit all-time highs Friday, in the latest signal that investor appetite for the biopharmaceutical sector is back.